Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) vs Rwanda: Proportion of the target population who received a 3rd dose of
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
84.0%
in 2024
Rwanda
98.0%
in 2024
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) rank
6th
Rwanda rank
7th
Proportion of the target population who received a 3rd dose of over time
- Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
- Rwanda
How they compare
Rwanda currently reports 98.0% against 84.0% in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand), a difference of 14.0%.
That makes Rwanda's figure about 1.2 times Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)'s.
Across all 15 years both countries report, Rwanda has been ahead every year.
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 6th and Rwanda ranks 7th of 37 groups.
Rwanda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 68.6% | 97.7% | 29.1% | Rwanda |
| 2020s | 83.6% | 93.6% | 10.0% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) or Rwanda?
- Rwanda, at 98.0% against 84.0% in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) and Rwanda?
- 14.0%, with Rwanda ahead.
- How many years of comparable data are there for Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) and Rwanda?
- 15 years are reported by both, from 2010 to 2024.
- How do Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) and Rwanda rank globally for proportion of the target population who received a 3rd dose of?
- Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 6th and Rwanda ranks 7th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.